COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review.

Adenovirus vector COVID-19 Healthcare worker SARS-CoV-2 Vaccine mRNA

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 18 07 2024
accepted: 05 08 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

Health care workers (HCWs) have been at increased risk of infection during the SARS-CoV-2 pandemic and as essential workers have been prioritised for vaccination. Due to increased exposure HCW are considered a predictor of what might happen in the general population, particularly working age adults. This study aims to summarise effect of vaccination in this 'at risk' cohort. Ovid MEDLINE and Embase were searched, and 358 individual articles were identified. Of these 49 met the inclusion criteria for review and 14 were included in a meta-analysis. Participants included were predominantly female and working age. Median time to infection was 51 days. Reported vaccine effectiveness against infection, symptomatic infection, and infection requiring hospitalisation were between 5 and 100 %, 34 and 100 %, and 65 and 100 % (respectively). No vaccinated HCW deaths were recorded in any study. Pooled estimates of protection against infection, symptomatic infection, and hospitalisation were, respectively, 84.7 % (95 % CI 72.6-91.5 %, Vaccination against SARS-CoV2 in HCWs is protective against infection, symptomatic infection, and hospitalisation. Waning protection is reported but this awaits more mature studies to understand durability more clearly. This study is limited by varying non-pharmacological responses to COVID-19 between included studies, a predominantly female and working age population, and limited information on asymptomatic transmission or long COVID protection.

Identifiants

pubmed: 39221179
doi: 10.1016/j.jvacx.2024.100546
pii: S2590-1362(24)00119-0
pmc: PMC11364133
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100546

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Oliver Galgut (O)

Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Fiona Ashford (F)

Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, UK.

Alexandra Deeks (A)

NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Andeep Ghataure (A)

College of Medical and Dental Science, University of Birmingham, Birmingham, UK.

Mimia Islam (M)

College of Medical and Dental Science, University of Birmingham, Birmingham, UK.

Tanvir Sambhi (T)

College of Medical and Dental Science, University of Birmingham, Birmingham, UK.

Yiu Wayn Ker (YW)

College of Medical and Dental Science, University of Birmingham, Birmingham, UK.

Christopher J A Duncan (CJA)

Translational and Clinical Research Institute Immunity and Inflammation Theme, Newcastle University, Newcastle, UK.
Department of Infection and Tropical Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.

Thushan I de Silva (TI)

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, PO Box 273, Fajara, the Gambia.

Susan Hopkins (S)

United Kingdom Health Security Agency, Colindale, London, UK.
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK.

Victoria Hall (V)

United Kingdom Health Security Agency, Colindale, London, UK.
NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, University of Oxford, Oxford, UK.

Paul Klenerman (P)

NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Translational Gastroenterology Unit, University of Oxford, Oxford, UK.

Susanna Dunachie (S)

NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand.

Alex Richter (A)

Institute of Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Classifications MeSH